,address1,address2,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,forwardPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,sharesShort,sharesShortPriorMonth,sharesShortPreviousMonthDate,dateShortInterest,sharesPercentSharesOut,heldPercentInsiders,heldPercentInstitutions,shortRatio,shortPercentOfFloat,bookValue,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,forwardEps,lastSplitFactor,lastSplitDate,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationMean,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,debtToEquity,returnOnAssets,returnOnEquity,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,343 Oyster Point Boulevard,Suite 200,South San Francisco,CA,94080,United States,(650) 870-1000,https://www.calithera.com,Biotechnology,Healthcare,"Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.",8,"{'maxAge': 1, 'name': 'Dr. Susan M. Molineaux Ph.D.', 'age': 68, 'title': 'Founder, CEO, Pres & Director', 'yearBorn': 1954, 'fiscalYear': 2022, 'totalPay': 625808, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.0,0.233056,-0.037037037,237,237,18224,932,932,0.0,0.0,1100,1000,243625,0.01,3.6838,0.0526,0.381716,0.0,0.0,USD,-1199375,0.0,4766618,4872500,417277,148514,1671062400,1673568000,0.0857,0.01074,0.00026,0.78,0.0892,-0.401,1672444800,1703980800,1672444800,-21290000,-7.94,-1.35,1:48,1411084800,0.029,PNK,EQUITY,CALA,CALA,CALITHERA BIOSCIENCES INC,"Calithera Biosciences, Inc.",1412256600,America/New_York,EDT,-14400000,0.05,3.0,hold,25451000,5.223,-41819000,1666000,3.444,3.603,8.17,-0.5629,-1.1414,-28174250,-43608000,0.0,0.0,0.0,USD,
1,343 Oyster Point Boulevard,Suite 200,South San Francisco,CA,94080,United States,(650) 870-1000,https://www.calithera.com,Biotechnology,Healthcare,"Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.",8,"{'maxAge': 1, 'name': 'Ms. Stephanie  Wong', 'age': 48, 'title': 'CFO & Sec.', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 752416, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.0,0.233056,-0.037037037,237,237,18224,932,932,0.0,0.0,1100,1000,243625,0.01,3.6838,0.0526,0.381716,0.0,0.0,USD,-1199375,0.0,4766618,4872500,417277,148514,1671062400,1673568000,0.0857,0.01074,0.00026,0.78,0.0892,-0.401,1672444800,1703980800,1672444800,-21290000,-7.94,-1.35,1:48,1411084800,0.029,PNK,EQUITY,CALA,CALA,CALITHERA BIOSCIENCES INC,"Calithera Biosciences, Inc.",1412256600,America/New_York,EDT,-14400000,0.05,3.0,hold,25451000,5.223,-41819000,1666000,3.444,3.603,8.17,-0.5629,-1.1414,-28174250,-43608000,0.0,0.0,0.0,USD,
2,343 Oyster Point Boulevard,Suite 200,South San Francisco,CA,94080,United States,(650) 870-1000,https://www.calithera.com,Biotechnology,Healthcare,"Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.",8,"{'maxAge': 1, 'name': 'Dr. Christopher J. Molineaux Ph.D.', 'age': 69, 'title': 'Sr. VP of Devel.', 'yearBorn': 1953, 'fiscalYear': 2014, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.0,0.233056,-0.037037037,237,237,18224,932,932,0.0,0.0,1100,1000,243625,0.01,3.6838,0.0526,0.381716,0.0,0.0,USD,-1199375,0.0,4766618,4872500,417277,148514,1671062400,1673568000,0.0857,0.01074,0.00026,0.78,0.0892,-0.401,1672444800,1703980800,1672444800,-21290000,-7.94,-1.35,1:48,1411084800,0.029,PNK,EQUITY,CALA,CALA,CALITHERA BIOSCIENCES INC,"Calithera Biosciences, Inc.",1412256600,America/New_York,EDT,-14400000,0.05,3.0,hold,25451000,5.223,-41819000,1666000,3.444,3.603,8.17,-0.5629,-1.1414,-28174250,-43608000,0.0,0.0,0.0,USD,
3,343 Oyster Point Boulevard,Suite 200,South San Francisco,CA,94080,United States,(650) 870-1000,https://www.calithera.com,Biotechnology,Healthcare,"Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.",8,"{'maxAge': 1, 'name': 'Mr. Frank  Parlati Ph.D.', 'age': 53, 'title': 'Sr. VP of Research', 'yearBorn': 1969, 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.0,0.233056,-0.037037037,237,237,18224,932,932,0.0,0.0,1100,1000,243625,0.01,3.6838,0.0526,0.381716,0.0,0.0,USD,-1199375,0.0,4766618,4872500,417277,148514,1671062400,1673568000,0.0857,0.01074,0.00026,0.78,0.0892,-0.401,1672444800,1703980800,1672444800,-21290000,-7.94,-1.35,1:48,1411084800,0.029,PNK,EQUITY,CALA,CALA,CALITHERA BIOSCIENCES INC,"Calithera Biosciences, Inc.",1412256600,America/New_York,EDT,-14400000,0.05,3.0,hold,25451000,5.223,-41819000,1666000,3.444,3.603,8.17,-0.5629,-1.1414,-28174250,-43608000,0.0,0.0,0.0,USD,
4,343 Oyster Point Boulevard,Suite 200,South San Francisco,CA,94080,United States,(650) 870-1000,https://www.calithera.com,Biotechnology,Healthcare,"Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.",8,"{'maxAge': 1, 'name': 'Dr. Susan B. Demo Ph.D.', 'title': 'Sr. VP of R&D Operations', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.0,0.233056,-0.037037037,237,237,18224,932,932,0.0,0.0,1100,1000,243625,0.01,3.6838,0.0526,0.381716,0.0,0.0,USD,-1199375,0.0,4766618,4872500,417277,148514,1671062400,1673568000,0.0857,0.01074,0.00026,0.78,0.0892,-0.401,1672444800,1703980800,1672444800,-21290000,-7.94,-1.35,1:48,1411084800,0.029,PNK,EQUITY,CALA,CALA,CALITHERA BIOSCIENCES INC,"Calithera Biosciences, Inc.",1412256600,America/New_York,EDT,-14400000,0.05,3.0,hold,25451000,5.223,-41819000,1666000,3.444,3.603,8.17,-0.5629,-1.1414,-28174250,-43608000,0.0,0.0,0.0,USD,
5,343 Oyster Point Boulevard,Suite 200,South San Francisco,CA,94080,United States,(650) 870-1000,https://www.calithera.com,Biotechnology,Healthcare,"Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.",8,"{'maxAge': 1, 'name': 'Dr. Allison  Dillon Ph.D.', 'title': 'Sr. VP of Commercial & Portfolio Strategy', 'exercisedValue': 0, 'unexercisedValue': 0}",1672444800,86400,4,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.05,0.0,0.233056,-0.037037037,237,237,18224,932,932,0.0,0.0,1100,1000,243625,0.01,3.6838,0.0526,0.381716,0.0,0.0,USD,-1199375,0.0,4766618,4872500,417277,148514,1671062400,1673568000,0.0857,0.01074,0.00026,0.78,0.0892,-0.401,1672444800,1703980800,1672444800,-21290000,-7.94,-1.35,1:48,1411084800,0.029,PNK,EQUITY,CALA,CALA,CALITHERA BIOSCIENCES INC,"Calithera Biosciences, Inc.",1412256600,America/New_York,EDT,-14400000,0.05,3.0,hold,25451000,5.223,-41819000,1666000,3.444,3.603,8.17,-0.5629,-1.1414,-28174250,-43608000,0.0,0.0,0.0,USD,
